RecruitingNCT03440177

Bariatric Surgery and Pharmacokinetics of Ramipril

Bariatric Surgery and Pharmacokinetics of Ramipril: BAR-MEDS Ramipril


Sponsor

Norwegian University of Science and Technology

Enrollment

12 participants

Start Date

Jan 2, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Changes to gastric pH, gastric emptying time, gastrointestinal transit-time or the pre-systemic metabolizing effect of enzymes secreted in the mucosa may all alter the pharmacokinetics of medicines. These factors are potentially influenced by bariatric surgery. Little is so far known about how gastric bypass and sleeve gastrectomy impacts the biological availability of medication. In this study we investigate the pharmacokinetic effects of bariatric surgery on ramipril.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ramipril for people with obesity, morbid. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRamipril

Patients are tested for their normal prescription ramipril medication


Locations(1)

St. Olavs University Hospital

Trondheim, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03440177


Related Trials